These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35908738)

  • 21. Age as a factor in treatment of aspirin-exacerbated respiratory disease: relationship to required aspirin maintenance dose after desensitization.
    Locke TB; Sweis AM; Gleeson PK; Lin TC; Civantos AM; Parhar HS; Corr AM; Kumar A; Salmon MK; Kohanski MA; Palmer JN; Bosso JV; Adappa ND
    Int Forum Allergy Rhinol; 2020 Oct; 10(10):1180-1181. PubMed ID: 32761891
    [No Abstract]   [Full Text] [Related]  

  • 22. A retrospective analysis of bronchiectasis in patients with aspirin-exacerbated respiratory disease.
    Chen YS; Bensko JC; Laidlaw TM; Buchheit KM
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2799-2801. PubMed ID: 32330669
    [No Abstract]   [Full Text] [Related]  

  • 23. Aspirin-exacerbated respiratory disease: burden of disease.
    Chang JE; White A; Simon RA; Stevenson DD
    Allergy Asthma Proc; 2012; 33(2):117-21. PubMed ID: 22525387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspirin-exacerbated respiratory disease: personalized medical and surgical approaches.
    Schlosser RJ
    Int Forum Allergy Rhinol; 2020 Sep; 10(9):1035-1036. PubMed ID: 32634286
    [No Abstract]   [Full Text] [Related]  

  • 25. Rhinosinusitis and nasal polyps in aspirin-exacerbated respiratory disease.
    Mullol J; Picado C
    Immunol Allergy Clin North Am; 2013 May; 33(2):163-76. PubMed ID: 23639706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicenter approach to evaluate omalizumab effectiveness in Samter's triad.
    Cameli P; D'Alessandro M; Bergantini L; Silvestri E; Romaldi A; Emmi G; Parronchi P; Bargagli E
    Monaldi Arch Chest Dis; 2020 Aug; 90(3):. PubMed ID: 32885934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease.
    Pezato R; Świerczyńska-Krępa M; Niżankowska-Mogilnicka E; Holtappels G; De Ruyck N; Sanak M; Derycke L; Van Crombruggen K; Bachert C; Pérez-Novo CA
    Cytokine; 2016 Jan; 77():157-67. PubMed ID: 26615369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Not Available].
    Borgeat Kaeser A; Ribi C
    Praxis (Bern 1994); 2017; 106(22):1243-1249. PubMed ID: 29088964
    [No Abstract]   [Full Text] [Related]  

  • 29. Samter's Triad to Aspirin-Exacerbated Respiratory Disease: Historical Perspective and Current Clinical Practice.
    Krouse HJ; Krouse JH
    ORL Head Neck Nurs; 2015; 33(4):14-8. PubMed ID: 26753248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptome Analysis Identifies Doublesex and Mab-3 Related Transcription Factor (DMRT3) in Nasal Polyp Epithelial Cells of Patients Suffering from Non-Steroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease (AERD).
    Priyadharshini VS; Jiménez-Chobillon MA; de Graaf J; Porras Gutiérrez de Velasco R; Gratziou C; Ramírez-Jiménez F; Teran LM
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive Analysis of Nasal Polyps Reveals a More Pronounced Type 2 Transcriptomic Profile of Epithelial Cells and Mast Cells in Aspirin-Exacerbated Respiratory Disease.
    Bangert C; Villazala-Merino S; Fahrenberger M; Krausgruber T; Bauer WM; Stanek V; Campion NJ; Bartosik T; Quint T; Regelsberger G; Niederberger-Leppin V; Bock C; Schneider S; Eckl-Dorna J
    Front Immunol; 2022; 13():850494. PubMed ID: 35418991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Long-term efficacy of aspirin desensitization in aspirin-exacerbated respiratory disease. Review of two clinical cases].
    Cambray-Gutiérrez JC; García-Ramírez UN; Del Rivero-Hernández LG; Lozano-Martínez SA; López-Pérez P; Chávez-García A
    Rev Alerg Mex; 2016; 63(2):207-12. PubMed ID: 27174764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspirin desensitization for patients with aspirin-exacerbated respiratory disease: A randomized double-blind placebo-controlled trial.
    Esmaeilzadeh H; Nabavi M; Aryan Z; Arshi S; Bemanian MH; Fallahpour M; Mortazavi N
    Clin Immunol; 2015 Oct; 160(2):349-57. PubMed ID: 26083948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term Clinical Outcomes of Aspirin Desensitization With Continuous Daily Aspirin Therapy in Aspirin-exacerbated Respiratory Disease.
    Walters KM; Waldram JD; Woessner KM; White AA
    Am J Rhinol Allergy; 2018 Jul; 32(4):280-286. PubMed ID: 29682983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poor control of asthma symptoms with interleukin-5 inhibitors in four patients with aspirin-exacerbated respiratory disease.
    Eid RC; Wudneh E; Zahid S; Cahill K; Jerschow E
    Ann Allergy Asthma Immunol; 2020 Jan; 124(1):102-104. PubMed ID: 31605753
    [No Abstract]   [Full Text] [Related]  

  • 36. The role of aspirin desensitization in patients with aspirin-exacerbated respiratory disease (AERD).
    Spies JW; Valera FC; Cordeiro DL; de Mendonça TN; Leite MG; Tamashiro E; Arruda LK; Anselmo-Lima WT
    Braz J Otorhinolaryngol; 2016; 82(3):263-8. PubMed ID: 26601997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspirin desensitization for aspirin-exacerbated respiratory disease in the era of biologics: Clinical perspective.
    Bosso JV
    Int Forum Allergy Rhinol; 2021 Apr; 11(4):822-823. PubMed ID: 33070455
    [No Abstract]   [Full Text] [Related]  

  • 38. Aspirin-exacerbated respiratory disease and current treatment modalities.
    Sakalar EG; Muluk NB; Kar M; Cingi C
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1291-1300. PubMed ID: 27538737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel treatment adjunct for aspirin exacerbated respiratory disease: the low-salicylate diet: a multicenter randomized control crossover trial.
    Sommer DD; Rotenberg BW; Sowerby LJ; Lee JM; Janjua A; Witterick IJ; Monteiro E; Gupta MK; Au M; Nayan S
    Int Forum Allergy Rhinol; 2016 Apr; 6(4):385-91. PubMed ID: 26751262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on aspirin desensitization for chronic rhinosinusitis with polyps in aspirin-exacerbated respiratory disease (AERD).
    Simon RA; Dazy KM; Waldram JD
    Curr Allergy Asthma Rep; 2015 Mar; 15(3):508. PubMed ID: 25663486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.